{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:27:52Z","timestamp":1740166072201,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s13760-023-02280-4","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T06:02:20Z","timestamp":1684562540000},"page":"1495-1503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden of migraine in patients attending Belgian headache specialists: real-world evidence from the BECOME study"],"prefix":"10.1007","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7603-1290","authenticated-orcid":false,"given":"Shantaily","family":"Lourens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Van Deun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Paemeleire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies","family":"Van Dycke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"De Klippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Schoenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefin","family":"Snellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Versijpt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"2280_CR1","unstructured":"World Health Organization. Headache disorders\u00a0(2016)\u00a0http:\/\/www.who.int\/mediacentre\/factsheets\/fs277\/en\/\u00a0"},{"key":"2280_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner TJ et al (2018) Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain 19:17","journal-title":"J Headache Pain"},{"key":"2280_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10194-019-0993-0","volume":"20","author":"M Leonardi","year":"2019","unstructured":"Leonardi M et al (2019) A narrative review on the burden of migraine: when the burden is the impact on people\u2019s life. J Headache Pain 20:41","journal-title":"J Headache Pain"},{"key":"2280_CR4","first-page":"954","volume":"17","author":"GBD","year":"2016","unstructured":"GBD (2016) Headache Collaborators (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:954\u2013976","journal-title":"Lancet Neurol"},{"issue":"10283","key":"2280_CR5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"Ashina","year":"2021","unstructured":"Ashina et al (2021) Migraine: epidemiology and systems of care. Lancet 397(10283):1485\u20131495","journal-title":"Lancet"},{"key":"2280_CR6","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"T Vos","year":"2016","unstructured":"Vos T et al (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet 388:1545\u20131602","journal-title":"Lancet"},{"key":"2280_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-018-0946-z","volume":"19","author":"P Martelletti","year":"2018","unstructured":"Martelletti P et al (2018) My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. J Headache Pain 19:115","journal-title":"J Headache Pain"},{"key":"2280_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/head.13966","author":"DC Buse","year":"2020","unstructured":"Buse DC et al (2020) Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. https:\/\/doi.org\/10.1111\/head.13966","journal-title":"Headache"},{"issue":"5","key":"2280_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10194-011-0356-y","volume":"12","author":"C Andr\u00e9e","year":"2011","unstructured":"Andr\u00e9e C et al (2011) The Eurolight project: the impact of primary headache disorders in Europe. Description of methods. J Headache Pain 12(5):541\u2013549","journal-title":"J Headache Pain"},{"issue":"3","key":"2280_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0333102410381145","volume":"31","author":"AM Blumenfeld","year":"2011","unstructured":"Blumenfeld AM et al (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 31(3):301\u2013315","journal-title":"Cephalalgia"},{"issue":"2","key":"2280_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/head.14056","volume":"61","author":"T Schwedt","year":"2021","unstructured":"Schwedt T et al (2021) Headache characteristics and burden from chronic migraine with medication overuse headache: cross-sectional observations from the Medication Overuse Treatment Strategy trial. Headache 61(2):351\u2013362","journal-title":"Headache"},{"key":"2280_CR12","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s40122-021-00331-3","volume":"10","author":"P Pozo-Rosich","year":"2021","unstructured":"Pozo-Rosich P et al (2021) Burden of migraine in patients with preventive treatment failure attending European headache specialist centers: real-world evidence from the BECOME study. Pain Ther 10:1691\u20131708","journal-title":"Pain Ther"},{"key":"2280_CR13","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M et al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727\u20131736","journal-title":"Qual Life Res"},{"key":"2280_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1046\/j.1526-4610.2000.00030.x","volume":"40","author":"B Martin","year":"2000","unstructured":"Martin B et al (2000) Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache 40:204\u2013215","journal-title":"Headache"},{"issue":"3","key":"2280_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/head.14031","volume":"61","author":"R Speck","year":"2021","unstructured":"Speck R et al (2021) Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine. Headache 61(3):511\u2013526","journal-title":"Headache"},{"issue":"5","key":"2280_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC et al (1993) The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4(5):353\u2013365","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"2280_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s41687-023-00552-4","volume":"7","author":"JH Ford","year":"2023","unstructured":"Ford JH et al (2023) Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine. J Patient Rep Outcomes 7(1):34","journal-title":"J Patient Rep Outcomes"},{"issue":"8","key":"2280_CR18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1023\/A:1026119331193","volume":"12","author":"M Kosinski","year":"2003","unstructured":"Kosinski M et al (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12(8):963\u2013974","journal-title":"Qual Life Res"},{"issue":"3","key":"2280_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/0333102410379890","volume":"31","author":"M Yang","year":"2011","unstructured":"Yang M et al (2011) Validation of the Headache Impact Test (HIT-6\u2122) across episodic and chronic migraine. Cephalalgia 31(3):357\u2013367","journal-title":"Cephalalgia"},{"issue":"6 Suppl 1","key":"2280_CR20","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1212\/WNL.56.suppl_1.S20","volume":"56","author":"Stewart","year":"2001","unstructured":"Stewart et al (2001) Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability. Neurology 56(6 Suppl 1):S20\u2013S28","journal-title":"Neurology"},{"issue":"5","key":"2280_CR21","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1212\/WNL.53.5.988","volume":"53","author":"W Stewart","year":"1999","unstructured":"Stewart W et al (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53(5):988\u2013994","journal-title":"Neurology"},{"key":"2280_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.genhosppsych.2017.06.006","volume":"48","author":"F Amoozegar","year":"2017","unstructured":"Amoozegar F et al (2017) The prevalence of depression and the accuracy of depression screening tools in migraine patients. Gen Hosp Psychiatry 48:25\u201331","journal-title":"Gen Hosp Psychiatry"},{"issue":"12","key":"2280_CR23","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jclinepi.2004.05.004","volume":"57","author":"M Martin","year":"2004","unstructured":"Martin M et al (2004) The Short-Form Headache Impact Test (HIT-6) was psychometrically equivalent in nine languages. J Clin Epidemiol 57(12):1271\u20131278","journal-title":"J Clin Epidemiol"},{"key":"2280_CR24","unstructured":"Bouckaert N et al (2021) An EQ-5D-5L value set for Belgium - how to value health related quality of life? Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). KCE Reports 342. D\/2021\/10.273\/19."},{"key":"2280_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12888-014-0354-0","volume":"14","author":"C Boc\u00e9r\u00e9an","year":"2014","unstructured":"Boc\u00e9r\u00e9an C et al (2014) A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees. BMC Psychiatry 14:354","journal-title":"BMC Psychiatry"},{"issue":"2","key":"2280_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1017\/S0033291796004382","volume":"27","author":"P Spinhoven","year":"1997","unstructured":"Spinhoven P et al (1997) A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27(2):363\u2013370","journal-title":"Psychol Med"},{"issue":"5","key":"2280_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1526-4610.2006.00430.x","volume":"46","author":"C Lucas","year":"2006","unstructured":"Lucas C et al (2006) Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey. Headache 46(5):715\u2013725","journal-title":"Headache"},{"issue":"7","key":"2280_CR28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/0333102411398400","volume":"31","author":"M Lanteri-Minet","year":"2011","unstructured":"Lanteri-Minet M et al (2011) Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia 31(7):837\u2013850","journal-title":"Cephalalgia"},{"key":"2280_CR29","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1186\/s12913-022-08191-z","volume":"22","author":"S Park","year":"2022","unstructured":"Park S et al (2022) The disease burden of migraine patients receiving prophylactic treatments in Korea: a population-based claims database analysis. BMC Health Serv Res 22:902","journal-title":"BMC Health Serv Res"},{"key":"2280_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s10194-016-0599-8","volume":"17","author":"C Lampl","year":"2016","unstructured":"Lampl C et al (2016) Interictal burden attributable to episodic headache: findings from the Eurolight project. J Headache Pain 17:9","journal-title":"J Headache Pain"},{"issue":"1","key":"2280_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10194-021-01243-5","volume":"22","author":"T Shimizu","year":"2021","unstructured":"Shimizu T et al (2021) Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain 22(1):29","journal-title":"J Headache Pain"},{"key":"2280_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-019-0964-5","volume":"20","author":"MA Korolainen","year":"2019","unstructured":"Korolainen MA et al (2019) Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care. J Headache Pain 20:1\u201316","journal-title":"J Headache Pain"},{"key":"2280_CR33","doi-asserted-by":"publisher","first-page":"100408","DOI":"10.1016\/j.ensci.2022.100408","volume":"27","author":"O Begasse de Dhaem","year":"2022","unstructured":"Begasse de Dhaem O et al (2022) Migraine in the workplace. eNeurologicalSci 27:100408","journal-title":"eNeurologicalSci"},{"key":"2280_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.yebeh.2015.12.018","volume":"55","author":"S Gupta","year":"2016","unstructured":"Gupta S et al (2016) Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: an analysis from the National Health and Wellness Survey. Epilepsy Behav 55:146\u2013156","journal-title":"Epilepsy Behav"},{"issue":"3","key":"2280_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.pain.2005.09.010","volume":"118","author":"M Lanteri-Minet","year":"2005","unstructured":"Lanteri-Minet M et al (2005) Anxiety and depression associated with migraine: influence on migraine subjects\u2019 disability and quality of life, and acute migraine management. Pain 118(3):319\u2013326","journal-title":"Pain"},{"issue":"2\u20133","key":"2280_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.eplepsyres.2008.10.004","volume":"83","author":"P Pe\u00f1a","year":"2009","unstructured":"Pe\u00f1a P et al (2009) Driving cost factors in adult outpatients with refractory epilepsy: a daily clinical practice in clinics of neurology in Spain. Epilepsy Res 83(2\u20133):133\u2013143","journal-title":"Epilepsy Res"},{"key":"2280_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11136-021-02971-6","volume":"31","author":"L Van Wilder","year":"2022","unstructured":"Van Wilder L et al (2022) Belgian population norms for the EQ-5D-5L, 2018. Qual Life Res 31:527\u2013537","journal-title":"Qual Life Res"},{"key":"2280_CR38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10198-017-0928-0","volume":"19","author":"B Wijnen","year":"2018","unstructured":"Wijnen B et al (2018) A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy. Eur J Health Econ 19:861\u2013870","journal-title":"Eur J Health Econ"},{"key":"2280_CR39","doi-asserted-by":"publisher","first-page":"1012486","DOI":"10.3389\/fneur.2022.1012486","volume":"13","author":"van Hezik-Wester","year":"2022","unstructured":"van Hezik-Wester (2022) Burden of illness in people with medically refractory epilepsy who suffer from daily to weekly seizures: 12-month follow-up of participants in the EPISODE study. Front Neurol 13:1012486","journal-title":"Front Neurol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02280-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-023-02280-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02280-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T09:37:25Z","timestamp":1689154645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-023-02280-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2280"],"URL":"https:\/\/doi.org\/10.1007\/s13760-023-02280-4","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"type":"print","value":"0300-9009"},{"type":"electronic","value":"2240-2993"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"2 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Koen Paemeleire has received personal compensation from Allergan\/Abbvie, Amgen\/Novartis, Eli Lilly, Lundbeck and Teva for consulting, serving on a scientific advisory board, and\/or speaking and is a clinical trial investigator for Amgen\/Novartis (erenumab), Eli Lilly (galcanezumab), and Autonomic Technologies Inc. (sphenopalatine ganglion stimulation). Josefin Snellman has received personal compensation from Allergan\/Abbvie, Amgen\/Novartis, Eli Lilly, Lundbeck, Teva, Cefaly Technology, Autonomic Technologies Inc. and Man & Science for consulting, serving on a scientific advisory board, and\/or speaking and is an investigator for Eli Lilly, Novartis, Lundbeck and Teva. Shannon Ritter and Josefin Snellman are full employees of Novartis. Jan Versijpt received personal fees and nonfinancial support from Teva, personal fees from Novartis and Lundbeck, and grants and nonfinancial support from Allergan\/Abbvie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}